We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
UK’s antitrust regulator has charged Pfizer and Flynn Pharma a fine totaling more than $100 million for hiking the prices of their phenytoin sodium capsules for epilepsy. Read More
Global drug spending will climb to $1.5 trillion in the next five years, marking a nearly 32 percent increase, fueled largely by new medicines and emerging markets. Read More
The U.S. government and life sciences industry groups have asked Japan not to change the country’s drug pricing system to annual price reviews and cuts, instead of the current every-two-year review. Read More
Eli Lilly has filed its tenth lawsuit against a drugmaker in the U.S. District Court for the Eastern District of Virginia, alleging infringement of a patent that covers its erectile dysfunction drug Cialis. Read More
Prescription drug spending rose 9 percent to $324.6 billion in 2015, outpacing national health expenditures in all other sectors, according to the Centers for Medicare & Medicaid Services. Read More
Five generics drugmakers are facing a class action lawsuit for allegedly colluding to inflate the price of a historically affordable generic anticonvulsant by more than 500 percent. Read More
An industry group has updated its pharmaceutical supply chain management guideline, implementing the latest changes in data standards ahead of federal standards mandating the ability to track and trace individual drug products. Read More
GlaxoSmithKline has filed an amicus brief in support of Bristol-Myers Squibb’s U.S. Supreme Court petition, which asks for a review of the California high court’s decision allowing plaintiffs outside the state to sue the drugmaker in the state’s court system. Read More